These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27030211)

  • 41. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
    Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA‑93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω.
    Ma C; Peng P; Zhou Y; Liu T; Wang L; Lu C
    Mol Med Rep; 2020 Jul; 22(1):483-493. PubMed ID: 32319642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases.
    Hussein NA; Ebid SA; Ahmad MA; Khedr GE; Saad DM
    Sci Rep; 2024 Apr; 14(1):8246. PubMed ID: 38589525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N6-methyladenosine modification of LATS2 promotes hepatoblastoma progression by inhibiting ferroptosis through the YAP1/ATF4/PSAT1 axis.
    Zhu G; Xie Y; Bian Z; Ma J; Zhen N; Chen T; Zhu J; Mao S; Tang X; Liu L; Gu S; Ding M; Pan Q
    Int J Biol Sci; 2024; 20(11):4146-4161. PubMed ID: 39247829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hippo signaling promotes JNK-dependent cell migration.
    Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.
    Adler JJ; Heller BL; Bringman LR; Ranahan WP; Cocklin RR; Goebl MG; Oh M; Lim HS; Ingham RJ; Wells CD
    J Biol Chem; 2013 May; 288(21):15181-93. PubMed ID: 23564455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth.
    Lignitto L; Arcella A; Sepe M; Rinaldi L; Delle Donne R; Gallo A; Stefan E; Bachmann VA; Oliva MA; Tiziana Storlazzi C; L'Abbate A; Brunetti A; Gargiulo S; Gramanzini M; Insabato L; Garbi C; Gottesman ME; Feliciello A
    Nat Commun; 2013; 4():1822. PubMed ID: 23652010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JCAD, a Gene at the 10p11 Coronary Artery Disease Locus, Regulates Hippo Signaling in Endothelial Cells.
    Jones PD; Kaiser MA; Ghaderi Najafabadi M; Koplev S; Zhao Y; Douglas G; Kyriakou T; Andrews S; Rajmohan R; Watkins H; Channon KM; Ye S; Yang X; Björkegren JLM; Samani NJ; Webb TR
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1711-1722. PubMed ID: 29794114
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Li L; Dong L; Wang Y; Zhang X; Yan J
    Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
    Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
    Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-429 Involves in the Pathogenesis of Colorectal Cancer via Directly Targeting LATS2.
    Chen X; Wang AL; Liu YY; Zhao CX; Zhou X; Liu HL; Lin MB
    Oxid Med Cell Longev; 2020; 2020():5316276. PubMed ID: 33414893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.
    Li C; Park S; Zhang X; Dai W; Xu D
    J Biol Chem; 2017 Jul; 292(27):11431-11444. PubMed ID: 28515325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
    Pérez M; García-Limones C; Zapico I; Marina A; Schmitz ML; Muñoz E; Calzado MA
    J Mol Cell Biol; 2012 Oct; 4(5):316-30. PubMed ID: 22878263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.